Fund Holdings — Samsara BioCapital, LLC

Total Portfolio Value:
$1.05B
Total Bought:
$153.32M
Total Sold:
$21.95M
Net Transaction:
+$131.37M
Notable People:
Michael Philip Dybbs
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Scholar Rock Holding Corporation(SRRK)6,897,6526,897,6520$379.37M$333.29M31.69%-$46.08M
Mineralys Therapeutics, Inc.(MLYS)5,871,0185,871,0180$158.40M$147.54M14.03%-$10.86M
Septerna, Inc.(SEPN)3,149,1283,066,453-82,675$105.46M$119.99M11.41%+$14.53M
Alamar Biosciences Inc2,480,3102,480,3100$67.19M$84.50M8.04%+$17.31M
SpyGlass Pharma, Inc.(SGP)2,109,9532,109,9530$46.97M$54.86M5.22%+$7.89M
Alumis Inc6,345,2197,235,809+890,590$178.55M$53.47M5.08%-$125.08M
Neurogene Inc.(NGNE)1,717,1271,867,127+150,000$54.00M$51.94M4.94%-$2.06M
Kalaris Therapeutics, Inc.(KLRS)12,881,17512,881,1750$52.43M$37.23M3.54%-$15.20M
Inventiva S.A.ADS(IVA)6,314,8056,314,8050$23.87M$23.30M2.22%-$568.3K
Parabilis Medicines Inc556,044556,0440$15.22M$17.95M1.71%+$2.74M
Sutro Biopharma, Inc.(STRO)1,062,8721,062,8720$35.29M$17.12M1.63%-$18.16M
PMV Pharmaceuticals, Inc.(PMVP)07,240,000+7,240,000$0$12.09M1.15%+$12.09M
Obsidian Therapeutics Inc0837,173+837,173$0$11.49M1.09%+$11.49M
Aquestive Therapeutics Inc2,500,0002,434,367-65,633$10.40M$11.27M1.07%+$871.1K
vTv Therapeutics Inc.CL A(VTVT)298,496354,730+56,234$11.24M$10.94M1.04%-$298.5K
Jade Biosciences Inc736,237736,2370$16.36M$10.34M0.98%-$6.02M
Nkarta, Inc.(NKTX)3,507,6663,507,6660$9.93M$9.19M0.87%-$736.6K
Rani Therapeutics Holdings, Inc.CL A(RANI)10,369,15910,369,1590$7.88M$8.20M0.78%+$317.3K
Artiva Biotherapeutics, Inc.(ARTV)954,861954,8610$9.26M$6.80M0.65%-$2.46M
AgomAb Therapeutics NVADS(AGMB)600,000594,749-5,251$7.79M$6.60M0.63%-$1.19M
Eloxx Pharmaceuticals Inc400,000400,0000$5.55M$6.12M0.58%+$572.0K
ABIVAX Société AnonymeADS(ABVX)55,09555,0950$7.34M$5.46M0.52%-$1.89M
Coherus Oncology, Inc.(CHRS)3,428,5713,383,565-45,006$4.80M$4.09M0.39%-$705.9K
X4 Pharmaceuticals, Inc.(XFOR)1,395,5871,347,723-47,864$6.52M$3.91M0.37%-$2.61M
Upstream Bio, Inc.(UPB)353,717300,361-53,356$2.45M$1.58M0.15%-$864.8K
Tcgx Acquisition CorpCL A0100,000+100,000$0$1.25M0.12%+$1.25M
Gossamer Bio Inc087,956+87,956$0$1.04M0.10%+$1.04M
Gossamer Bio, Inc.(GOSS)7,222,5590-7,222,559$1.19M$0—-$1.19M
Page 1 of 1
Samsara BioCapital, LLC — 13F Holdings — Q3 2026 | TickerTrail